ACUTA CAPITAL PARTNERS, LLC — 13F Holdings & Portfolio
CIK 1582844 · latest 13F-HR filed 2026-05-15
ACUTA CAPITAL PARTNERS, LLC manages $141.8M in 13F-reported U.S. long-equity assets across 27 reported positions as of its 2026-03-31 13F-HR filing. Its largest disclosed positions are PRAX (19.30%), TERN (18.44%), WHWK (8.30%). Quarter over quarter (versus its 2025-12-31 filing) the fund opened 5 new positions, exited 9, added to 14, and trimmed 6.
AUM is the long-equity portion reported on Form 13F-HR. Excludes short positions, cash, foreign holdings, and non-13F assets. For informational purposes only — not investment advice.
$141.8M
Long-equity book
27
Distinct positions
2026-03-31
Filed 2026-05-15
+5 / −9 / ↑14 / ↓6
vs 2025-12-31
| Name | Title / Status | Ownership | Type |
|---|
Top Adds (vs prior quarter)
- TANGO THERAPEUTICS INC$6.7M +269.0%
- SUTRO BIOPHARMA INC$5.9M +760.0%
- WHITEHAWK THERAPEUTICS INC$3.5M +42.6%
- PRAXIS PRECISION MEDICINES I$2.9M +11.8%
- MOONLAKE IMMUNOTHERAPEUTICS$2.8M +357.5%
Top Trims
- OCULAR THERAPEUTIX INC-$7.8M -60.8%
- AMYLYX PHARMACEUTICALS INC-$1.9M -47.8%
- COMPASS THERAPEUTICS INC-$1.4M -23.5%
- ARGEN SE - ADR-$654.6K -16.0%
- TAYSHA GENE THERAPIES INC-$537.1K -21.5%
New Positions
- ERASCA INC$5.7M
- 4D MOLECULAR THERAPEUTICS INC$2.3M
- IDEAYA BIOSCIENCES INC$1.6M
- ENTRADA THERAPEUTICS INC$1.1M
- AVALO THERAPEUTICS INC$907.9K
Exited Positions
- CIDARA THERAPEUTICS INC$19.7M
- JAZZ PHARMACEUTICALS PLC$4.9M
- INSMED INC$4.5M
- ZYMEWORKS INC$2.1M
- INHIBRX BIOSCIENCES INC$1.3M
Rows tagged Call or Put are options positions, not stock. Per SEC Form 13F-HR, Value shows the notional value of the underlying (shares covered × underlying price), not the option premium. Shares is the number of underlying shares covered (divide by 100 for contract count).
| # | Issuer | Symbol | CUSIP | Value | Weight | Shares | Type |
|---|---|---|---|---|---|---|---|
| 1 | PRAXIS PRECISION MEDICINES I | PRAX | 74006W207 | $27.4M | 19.30% | 84,901 | SH |
| 2 | TERNS PHARMACEUTICALS INC | TERN | 880881107 | $26.1M | 18.44% | 495,772 | SH |
| 3 | WHITEHAWK THERAPEUTICS INC | WHWK | 00032Q104 | $11.8M | 8.30% | 3,410,402 | SH |
| 4 | TANGO THERAPEUTICS INC | TNGX | 87583X109 | $9.2M | 6.52% | 441,831 | SH |
| 5 | BRIGHT MINDS BIOSCIENCES INC | DRUG | 10919W405 | $8.2M | 5.76% | 111,996 | SH |
| 6 | SUTRO BIOPHARMA INC | STRO | 869367201 | $6.7M | 4.73% | 269,425 | SH |
| 7 | ERASCA INC | ERAS | 29479A108 | $5.7M | 4.05% | 354,575 | SH |
| 8 | SURROZEN INC | SRZN | 86889P208 | $5.0M | 3.55% | 172,847 | SH |
| 9 | OCULAR THERAPEUTIX INC | OCUL | 67576A100 | $5.0M | 3.54% | 592,108 | SH |
| 10 | COMPASS THERAPEUTICS INC | CMPX | 20454B104 | $4.5M | 3.17% | 849,076 | SH |
| 11 | MINERVA NEUROSCIENCES | NERV | 603380205 | $4.3M | 3.02% | 709,500 | SH |
| 12 | MOONLAKE IMMUNOTHERAPEUTICS | MLTX | 61559X104 | $3.6M | 2.52% | 191,760 | SH |
| 13 | ARGEN SE - ADR | ARGX | 04016X101 | $3.4M | 2.42% | 4,690 | SH |
| 14 | OCULIS HOLDING AG | OCS | H5870P102 | $2.6M | 1.84% | 98,339 | SH |
| 15 | REVOLUTION MEDICINES INC | RVMD | 76155X100 | $2.5M | 1.79% | 26,069 | SH |
| 16 | 4D MOLECULAR THERAPEUTICS INC | FDMT | 35104E104 | $2.3M | 1.59% | 242,255 | SH |
| 17 | AMYLYX PHARMACEUTICALS INC | AMLX | 03237H101 | $2.1M | 1.48% | 151,067 | SH |
| 18 | TAYSHA GENE THERAPIES INC | TSHA | 877619106 | $2.0M | 1.39% | 439,464 | SH |
| 19 | IDEAYA BIOSCIENCES INC | IDYA | 45166A102 | $1.6M | 1.13% | 48,234 | SH |
| 20 | DESIGN THERAPEUTICS INC | DSGN | 25056L103 | $1.6M | 1.10% | 145,900 | SH |
| 21 | UNITED THERAPEUTICS CORP | UTHR | 91307C102 | $1.3M | 0.93% | 2,224 | SH |
| 22 | IDEAYA BIOSCIENCES INC Call | IDYA | 45166A102 | $1.2M | 0.82% | 350 | SH |
| 23 | ENTRADA THERAPEUTICS INC | TRDA | 29384C108 | $1.1M | 0.80% | 89,358 | SH |
| 24 | AVALO THERAPEUTICS INC | AVTX | 05338F306 | $907.9K | 0.64% | 60,808 | SH |
| 25 | LB PHARMACEUTICALS INC | LBRX | 50180M108 | $713.1K | 0.50% | 28,919 | SH |
| 26 | MAZE THERAPEUTICS INC | MAZE | 578784100 | $577.1K | 0.41% | 19,335 | SH |
| 27 | UNICYCIVE THERAPEUTICS INC | UNCY | 90466Y202 | $381.4K | 0.27% | 57,959 | SH |
| Period | Filed | AUM | Holdings | Accession |
|---|---|---|---|---|
| 2026-03-31 | 2026-05-15 | $141.8M | 27 | 0001104659-26-062163 |
| 2025-12-31 | 2026-02-17 | $147.3M | 30 | 0001104659-26-016119 |
| 2025-09-30 | 2025-11-14 | $96.8M | 28 | 0001104659-25-112378 |